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It has been kindly pointed out to us by Dr.
Omer Dushek of Oxford University that the
thermodynamic constraints (arising from
the principle of detailed balance) impose
the following condition on the parameters:
ν = γkinδ (1)
which means that the parameter ν is fixed
once γkin and δ have each been assigned
a value. The objective of the paper was
to exhibit the range of qualitative behav-
iors that is possible when pMHCI/CD8
kinetics interacts with TCR/pMHCI kinet-
ics and to show how varying levels of the
co-receptor at the T-cell surface may be
able to modulate the functional sensitiv-
ity of the T-cell to various ligands in a
differential fashion. These qualitative phe-
nomena remain very much the same when
we choose parameter values that respect the
constraint ν= γkinδ, as shown in the cor-
rected figures that follow below (Figures 2–
4). It is these qualitative patterns that are
currently guiding experimental research to
elucidate CD8-mediated ligand focusing in
the T-cell system. The main thrust of the
paper is therefore unaltered.
The kinetic scheme (Figure 1) and the
equations are all unaltered, except for a
typographical error in the subscript of a
quantity appearing in one of the equations.
Specifically, equation (23) in the published
text should read:
W = MRλ−1P00 +MXRλ−4P∗0 . (2)
We apologize profusely for any inconve-
nience our oversight may have caused.
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FIGURE 2 | (A) Scaled functional sensitivity w as a function of scaled
total CD8 density xT for various scaled TCR/pMHCI off-rates α.
(B) Degeneracy curves P(w>ω) for various scaled total CD8 density xT.
(C)The probability P(w>ω) as a function of CD8 density xT, at a set value
of functional sensitivity ω=0.14. The operating range of the probability P
is shown as a function of xT with dashed lines at P(w>0.14)=10−8 and
P(w>0.14)=10−5. Parameters are as follows: δ = 300,n = 100,
γkin = 0.1, γoff = 0.5, γR = 1, κ = 5.5,mT = 10, rT = 10. The log-normal
distribution has mean 2 and SD 0.2. Changed: ω=0.14, γkin, γR,κ and
α’s in (A).
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FIGURE 3 | Scaled functional sensitivity w as a function of scaled
total CD8 density xT. (A) Curves for various values of the scaled
TCR/pMHCI off-rate α. (B) Curves for various values of the factor γR by
which CD8 modulates the TCR triggering threshold. Parameters, unless
stated otherwise, are as follows: δ = 2.5,n = 100, γkin = 0.5, γoff = 0.5,
γR = 0.7, κ = 1,mT = 10, rT = 10, α = 1. Changed: γR.
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FIGURE 4 | Scaled functional sensitivity w as a function of
scaled total CD8 density xT. (A) Curves for various values of the
scaled TCR/pMHCI off-rate α. (B) Curves for various values of the
dimensionless factor γoff expressing the modulatory effect of CD8 on
the TCR/pMHCI off-rate. Parameters, unless stated otherwise, are
as follows: δ = 500, n = 100, γkin = 0.2, γoff = 0.2, γR = 0.01, κ = 1,
mT = 10, rT = 10, α = 1. Changed: δ, γkin, γR,α,κ, and α’s in (A) and
γoff’s in (B).
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FIGURE 5 | (A) Scaled functional sensitivity w as a function of scaled
TCR/pMHCI off-rate α. (B) Degeneracy curves P(w> ω) for HLA A*0201
mutants with altered binding affinity for CD8: A245V (dotted line),
wild-type (semi-dashed line), Q115E (dashed line), and A2/α3kb (solid line).
The three regions represent the overall pattern of CD8+ T-cell antigen
specificity and the arrow indicates the strength of pMHCI/CD8
interaction. Wild-type parameters are as follows: δ = 0.2, n = 100,
γkin = 0.5, γoff = 0.5, γR = 0.2, κ = 1, mT = 10, rT = 10, xT = 10; the
parameter δ is adjusted in proportion to the ratio between the mutant
pMHCI/CD8 affinity constant (i.e., dissociation constant) and the wild-type
affinity, whereas the parameters κ and xT are adjusted in inverse
proportion to the mutant/wild-type pMHCI/CD8 affinity (these
adjustments follow from the scaling). The log-normal distribution has
mean 5 and SD 0.5. Figure 5C has been deleted.
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